# Radiation Therapy in Treating Patients With Brain Cancer

> **NCT00002620** · PHASE3 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 212 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** carmustine
- **DRUG:** chemotherapy
- **DRUG:** mitolactol
- **RADIATION:** low-LET cobalt-60 gamma ray therapy
- **RADIATION:** low-LET photon therapy

## Key facts

- **NCT ID:** NCT00002620
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-11
- **Primary completion:** 2000-06
- **Final completion:** —
- **Target enrollment:** 212 (ESTIMATED)
- **Last updated:** 2012-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002620, "Radiation Therapy in Treating Patients With Brain Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00002620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*